Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study

Background Using double inversion recovery (DIR) MRI, cortical lesions can be seen in the brain of patients with multiple sclerosis (MS). The burden of such lesions seems to be well correlated with the severity of MS-related disability. Objective To investigate whether the extent of cortical damage in patients with benign MS (BMS) might contribute to explain their favorable clinical status. Methods Forty-eight patients with BMS (Expanded Disability Status Scale [EDSS] score ≤3.0 and disease duration ≥15 years) and 96 patients with non-disabling, early relapsing–remitting (RR) MS (EDSS score ≤3.0 and disease duration ≤5 years) were studied. Brain MRI, including a DIR and a fluid-attenuated inversion recovery (FLAIR) sequence, was acquired at baseline and after 12 months. On DIR images, intracortical (ICL) and cortical-subcortical lesions (CSL) were identified and their number and volume calculated. Total white matter (WM) lesion volume was quantified on FLAIR images. Results Compared with early RRMS, patients with BMS had lower number of ICL at both study time points (P ≤ 0.001 for both comparisons). At one-year follow-up, a significant increase of ICL and CSL number and total volume was observed only in early patients with RRMS. The number and volume of cortical lesions was not correlated with WM lesion volume. Total ICL number at baseline, total cortical lesion volume at baseline, and total cortical lesion volume change were independent predictors of MS phenotype. Conclusion In patients with BMS, the selective sparing of the cortex from disease-related focal pathology might be one of the factors associated to their favorable clinical status, independently of the (possible) accrual of WM lesions.

[1]  Marco Rovaris,et al.  Cognitive impairment and structural brain damage in benign multiple sclerosis , 2008, Neurology.

[2]  G. Siracusa,et al.  Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis , 2008, Neurology.

[3]  S Ropele,et al.  Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox? , 2008, Multiple sclerosis.

[4]  Giuseppe Scotti,et al.  The topographical distribution of tissue injury in benign MS: A 3T multiparametric MRI study , 2008, NeuroImage.

[5]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[6]  P. Narayana,et al.  Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging , 2007, American Journal of Neuroradiology.

[7]  M. Amato,et al.  LONGITUDINAL FOLLOW-UP OF “BENIGN” MULTIPLE SCLEROSIS AT 20 YEARS , 2007, Neurology.

[8]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[9]  Massimo Filippi,et al.  Functional MRI in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[10]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[11]  Chiara Romualdi,et al.  Cortical atrophy is relevant in multiple sclerosis at clinical onset , 2007, Journal of Neurology.

[12]  S. Sorbi,et al.  The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population , 2006, Multiple sclerosis.

[13]  M. Rovaris,et al.  Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.

[14]  M Rovaris,et al.  Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. , 2006, Brain : a journal of neurology.

[15]  M. Battaglini,et al.  Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. , 2006, Brain : a journal of neurology.

[16]  S. Sorbi,et al.  Neocortical volume decrease in relapsing–remitting multiple sclerosis with mild cognitive impairment , 2006, Journal of the Neurological Sciences.

[17]  J. De Keyser,et al.  Benign course in multiple sclerosis: a review , 2006, Acta neurologica Scandinavica.

[18]  L. Rambaud,et al.  Dual Inversion Recovery MRI Helps Identifying Cortical Tubers in Tuberous Sclerosis , 2006, Epilepsia.

[19]  John S. Duncan,et al.  Imaging the neocortex in epilepsy with double inversion recovery imaging , 2006, NeuroImage.

[20]  M. Filippi,et al.  Functional MRI to study brain plasticity in clinical neurology , 2006, Neurological Sciences.

[21]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[22]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[23]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[24]  M. Rovaris,et al.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. , 2005, AJNR. American journal of neuroradiology.

[25]  D. Louis Collins,et al.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.

[26]  John Noseworthy,et al.  Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study , 2004, Annals of neurology.

[27]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[28]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[29]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[30]  P Kapeller,et al.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[31]  N. Maurits,et al.  Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review , 2001, Multiple sclerosis.

[32]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[33]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[34]  B. Weinshenker,et al.  Multiple sclerosis. , 2000, The New England journal of medicine.

[35]  G V McDonnell,et al.  Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors , 1999, Journal of neurology, neurosurgery, and psychiatry.

[36]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[37]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[38]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[39]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.